drugset / Trial / NCT00305604

Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)

NCT00305604

Phase 3 Completed 206 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the effect of treatment with sitagliptin compared to placebo in elderly patients with type 2 diabetes mellitus who have poor glycemic control with diet and exercise.

Timeline

Start
2006-03-08
Primary completion
2008-03-12
Completion
2008-03-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sitagliptin Small molecule 50 mg Oral
Comparator Sitagliptin Small molecule 100 mg Oral